Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps.

Saved in:
Bibliographic Details
Title: Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps.
Authors: Wei B; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., Gan W; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., Li J; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., Wang F; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., Wang J; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., Wang B; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China., He J; Renji Medical Research Center, Chengdu Second People's Hospital, Chengdu, China., Liu F; Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 15; Vol. 17, pp. 1792878. Date of Electronic Publication: 2026 Jun 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1792878